Cargando…
CAR-NK Cells: A Chimeric Hope or a Promising Therapy?
SIMPLE SUMMARY: In recent years, innovative immunotherapy-based treatments have paved the way for a new approach to hematological malignancies. Instead of conventional chemotherapy, T cells have been genetically engineered to detect—and engage their cytotoxicity against—tumor cells, and their succes...
Autores principales: | Sabbah, Mohamad, Jondreville, Ludovic, Lacan, Claire, Norol, Francoise, Vieillard, Vincent, Roos-Weil, Damien, Nguyen, Stéphanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367380/ https://www.ncbi.nlm.nih.gov/pubmed/35954502 http://dx.doi.org/10.3390/cancers14153839 |
Ejemplares similares
-
CAR T-cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes
por: Lacan, Claire, et al.
Publicado: (2023) -
CAR-NK cell therapeutics for hematologic malignancies: hope is on the horizon
por: Xu, Kai-lin, et al.
Publicado: (2019) -
NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development
por: Bashiri Dezfouli, Ali, et al.
Publicado: (2021) -
CAR-NK cells: A promising cellular immunotherapy for cancer
por: Xie, Guozhu, et al.
Publicado: (2020) -
CAR‐NK cell in cancer immunotherapy; A promising frontier
por: Marofi, Faroogh, et al.
Publicado: (2021)